The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

Authors

Tianmeng Wen (ORCID: https://orcid.org/0000-0001-8363-3425)
You‐Lin Qiao (ORCID: https://orcid.org/0000-0001-6380-0871)
Fanghui Zhao (ORCID: https://orcid.org/0000-0001-9294-0005)
Huan Zhao (ORCID: https://orcid.org/0000-0003-0711-3860)
Shangying Hu (ORCID: https://orcid.org/0000-0002-4778-1612)
Xun Zhang (ORCID: https://orcid.org/0000-0002-8501-1969)
Xiaoqian Xu (ORCID: https://orcid.org/0000-0001-9269-2283)
Chenghao Pan

Institutions

Capital University (US)
Capital Medical University (CN)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Peking Union Medical College Hospital (CN)
National Clinical Research Center for Digestive Diseases (CN)
Beijing Friendship Hospital (CN)

Publication Details

Journal: Human Vaccines & Immunotherapeutics
Published: 2024-10-11
DOI: https://doi.org/10.1080/21645515.2024.2412391
Citations: 2
Primary Topic: Cervical Cancer and HPV Research
Type: article
Field-Weighted Citation Impact: 0.77

Funders

World Health Organization
Chinese Academy of Medical Sciences
Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

Tianmeng Wen, You‐Lin Qiao, Fanghui Zhao, Huan Zhao et al.

Oct 11, 2024

2 citations

Human Vaccines & Immunotherapeutics

Cervical Cancer and HPV Research

0.77

article

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

Tianmeng Wen, You‐Lin Qiao, Fanghui Zhao, Huan Zhao, Shangying Hu, Xun Zhang, Xiaoqian Xu, Chenghao Pan

October 11, 2024article en

2 citations

Abstract

No abstract available for this paper.

Human Vaccines & ImmunotherapeuticsVol. 20(1)

Capital University (US), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), National Clinical Research Center for Digestive Diseases (CN), Beijing Friendship Hospital (CN)

World Health Organization, Chinese Academy of Medical Sciences, Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Good health and well-being

Openalex Percentile: Top 25%

Cervical Cancer and HPV Research

0.77

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age — Tianmeng Wen, You‐Lin Qiao, et al. · Human Vaccines & Immunotherapeutics (2024) | TGRS Research Map | TGRS